NCT05755919 Functional Brain Mapping for Patients with Epilepsy
| NCT ID | NCT05755919 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wayne State University |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-05-16 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2022-05-16 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to determine the clinical utility of 'dynamic tractography': a novel method for visualizing electrical neural transfers that incorporates the underlying white matter tracts and supporting linguistic processing. We will also determine how well objective electrophysiology biomarkers will improve the prediction of language outcomes following epilepsy surgery. This project will ultimately optimize understanding of how the human brain develops its language network dynamics.
Eligibility Criteria
Inclusion Criteria: * Epilepsy surgery with extraoperative intracranial EEG recording with subdural or depth electrodes. Exclusion Criteria: * Patients with a malignant brain tumor, or progressive neurodegenerative or metabolic disorders who are not considered candidates for intracranial EEG recording.
Contact & Investigator
Eishi Asano, MD, PhD
PRINCIPAL INVESTIGATOR
Wayne State University
Frequently Asked Questions
Who can join the NCT05755919 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, up to 21 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05755919 currently recruiting?
Yes, NCT05755919 is actively recruiting participants. Contact the research team at easano@med.wayne.edu for enrollment information.
Where is the NCT05755919 trial being conducted?
This trial is being conducted at Detroit, United States, Detroit, United States.
Who is sponsoring the NCT05755919 clinical trial?
NCT05755919 is sponsored by Wayne State University. The principal investigator is Eishi Asano, MD, PhD at Wayne State University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.